135 related articles for article (PubMed ID: 38486429)
1. Single-Atom Catalysts Mediated Bioorthogonal Modulation of N
Sun M; Liu X; Liu Z; Zhang W; Li G; Ren J; Qu X
J Am Chem Soc; 2024 Mar; 146(12):8216-8227. PubMed ID: 38486429
[TBL] [Abstract][Full Text] [Related]
2. In situ activation of therapeutics through bioorthogonal catalysis.
Wang W; Zhang X; Huang R; Hirschbiegel CM; Wang H; Ding Y; Rotello VM
Adv Drug Deliv Rev; 2021 Sep; 176():113893. PubMed ID: 34333074
[TBL] [Abstract][Full Text] [Related]
3. The
Liu Y; Liu Z; Tang H; Shen Y; Gong Z; Xie N; Zhang X; Wang W; Kong W; Zhou Y; Fu Y
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C762-C775. PubMed ID: 31365297
[TBL] [Abstract][Full Text] [Related]
4. Bioorthogonal-Activated In Situ Vaccine Mediated by a COF-Based Catalytic Platform for Potent Cancer Immunotherapy.
Sun M; Liu Z; Wu L; Yang J; Ren J; Qu X
J Am Chem Soc; 2023 Mar; 145(9):5330-5341. PubMed ID: 36815731
[TBL] [Abstract][Full Text] [Related]
5. Liquid Metal as Bioinspired and Unusual Modulator in Bioorthogonal Catalysis for Tumor Inhibition Therapy.
Zhang L; Sang Y; Liu Z; Wang W; Liu Z; Deng Q; You Y; Ren J; Qu X
Angew Chem Int Ed Engl; 2023 Feb; 62(9):e202218159. PubMed ID: 36578232
[TBL] [Abstract][Full Text] [Related]
6. m
Peng C; Xiong F; Pu X; Hu Z; Yang Y; Qiao X; Jiang Y; Han M; Wang D; Li X
Front Immunol; 2023; 14():1326031. PubMed ID: 38187373
[TBL] [Abstract][Full Text] [Related]
7. Nanomaterial-based bioorthogonal nanozymes for biological applications.
Fedeli S; Im J; Gopalakrishnan S; Elia JL; Gupta A; Kim D; Rotello VM
Chem Soc Rev; 2021 Dec; 50(24):13467-13480. PubMed ID: 34787131
[TBL] [Abstract][Full Text] [Related]
8. Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer.
He S; Song W; Cui S; Li J; Jiang Y; Chen X; Peng L
Cell Oncol (Dordr); 2023 Dec; 46(6):1731-1746. PubMed ID: 37402945
[TBL] [Abstract][Full Text] [Related]
9. A DNA-Gated and Self-Protected Bioorthogonal Catalyst for Nanozyme-Assisted Safe Cancer Therapy.
Zhang Y; Zhang L; Wang W; Deng Q; Liu M; Zhu Z; Liu H; Ren J; Qu X
Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202306395. PubMed ID: 37268594
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable nanoemulsion-based bioorthogonal nanocatalysts for intracellular generation of anticancer therapeutics.
Nabawy A; Gupta A; Jiang M; Hirschbiegel CM; Fedeli S; Chattopadhyay AN; Park J; Zhang X; Liu L; Rotello VM
Nanoscale; 2023 Aug; 15(33):13595-13602. PubMed ID: 37554065
[TBL] [Abstract][Full Text] [Related]
11. Progress in controllable bioorthogonal catalysis for prodrug activation.
Liu X; Huang T; Chen Z; Yang H
Chem Commun (Camb); 2023 Oct; 59(84):12548-12559. PubMed ID: 37791560
[TBL] [Abstract][Full Text] [Related]
12. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
Front Immunol; 2021; 12():773570. PubMed ID: 34956201
[TBL] [Abstract][Full Text] [Related]
13. m
Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
[TBL] [Abstract][Full Text] [Related]
14. Precise Design of Atomically Dispersed Fe, Pt Dinuclear Catalysts and Their Synergistic Application for Tumor Catalytic Therapy.
Wang S; Hu Z; Wei Q; Cui P; Zhang H; Tang W; Sun Y; Duan H; Dai Z; Liu Q; Zheng X
ACS Appl Mater Interfaces; 2022 May; 14(18):20669-20681. PubMed ID: 35471816
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
16. Intracellular Activation of Anticancer Therapeutics Using Polymeric Bioorthogonal Nanocatalysts.
Zhang X; Landis RF; Keshri P; Cao-Milán R; Luther DC; Gopalakrishnan S; Liu Y; Huang R; Li G; Malassiné M; Uddin I; Rondon B; Rotello VM
Adv Healthc Mater; 2021 Mar; 10(5):e2001627. PubMed ID: 33314745
[TBL] [Abstract][Full Text] [Related]
17. Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells.
Wang F; Zhang Y; Du Z; Ren J; Qu X
Nat Commun; 2018 Mar; 9(1):1209. PubMed ID: 29572444
[TBL] [Abstract][Full Text] [Related]
18. Rational Utilization of Black Phosphorus Nanosheets to Enhance Palladium-Mediated Bioorthogonal Catalytic Activity for Activation of Therapeutics.
Rong M; Liu J; Sun Z; Li T; Li Y; Jiang C; Lu L
Angew Chem Int Ed Engl; 2023 May; 62(19):e202216822. PubMed ID: 36917027
[TBL] [Abstract][Full Text] [Related]
19. Bioorthogonal nanozymes for breast cancer imaging and therapy.
Zhang X; Liu Y; Doungchawee J; Castellanos-García LJ; Sikora KN; Jeon T; Goswami R; Fedeli S; Gupta A; Huang R; Hirschbiegel CM; Cao-Milán R; Majhi PKD; Cicek YA; Liu L; Jerry DJ; Vachet RW; Rotello VM
J Control Release; 2023 May; 357():31-39. PubMed ID: 36948419
[TBL] [Abstract][Full Text] [Related]
20. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
